| Advances in pemphigus therapy. | |
| | |
MedLine Citation:
|
PMID: 18506357 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The pemphigus variants represent a group of potentially life-threatening autoimmune mucocutaneous blistering diseases. Though systemic corticosteroids have dramatically reduced the rate of disease mortality, current therapeutic options are limited by their toxicity profiles. Advancements in our understanding of the molecular mechanisms involved in the pathogenesis of pemphigus have translated into the development of novel therapies. However, few treatments have been subject to randomized controlled trials to firmly establish therapeutic efficacy. Herein, we focus on the new and emerging therapies in the management of pemphigus. |
| | |
Authors:
|
V Prajapati; P R Mydlarski |
Related Documents
:
|
18567837 - Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-ol... 10426357 - Monitoring relapsing remitting ms patients. 18348877 - The use of hyperbaric oxygen therapy in ophthalmology. 23244617 - The thioredoxin system as a therapeutic target in human health and disease. 19623287 - Mastocytosis: a disease of the hematopoietic stem cell. 18560237 - Late-onset autoimmunity: the paradigm of primary biliary cirrhosis--a mini-review. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Skin therapy letter Volume: 13 ISSN: 1201-5989 ISO Abbreviation: Skin Therapy Lett. Publication Date: 2008 Apr |
Date Detail:
|
Created Date: 2008-05-28 Completed Date: 2008-07-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9891441 Medline TA: Skin Therapy Lett Country: Canada |
Other Details:
|
Languages: eng Pagination: 4-7 Citation Subset: IM |
Affiliation:
|
Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Inflammatory Agents
/
therapeutic use Glucocorticoids / therapeutic use* Humans Immunoglobulins, Intravenous / therapeutic use Immunologic Factors / therapeutic use Immunosorbents / therapeutic use Immunosuppressive Agents / therapeutic use Pemphigus / therapy* Photopheresis Plasmapheresis |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents; 0/Glucocorticoids; 0/Immunoglobulins, Intravenous; 0/Immunologic Factors; 0/Immunosorbents; 0/Immunosuppressive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Topical therapy for the management of childhood psoriasis: part I.
Next Document: Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal ox...